Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Sees Significant Increase in Short Interest

Posted by Doug Wharley on Jul 13th, 2026

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totaling 29,843 shares, an increase of 285.9% from the June 15th total of 7,733 shares. Currently, 3.3% of the company’s stock are short sold. Based on an average daily volume of 9,737 shares, the days-to-cover ratio is presently 3.1 days.

Institutional Investors Weigh In On Virtus LifeSci Biotech Products ETF

Several institutional investors and hedge funds have recently made changes to their positions in the company. Prime Capital Investment Advisors LLC purchased a new position in Virtus LifeSci Biotech Products ETF in the 4th quarter worth approximately $1,896,000. Flow Traders U.S. LLC purchased a new stake in Virtus LifeSci Biotech Products ETF during the 2nd quarter valued at $431,000. Finally, Comprehensive Financial Planning Inc. PA bought a new stake in shares of Virtus LifeSci Biotech Products ETF in the 4th quarter worth $557,000.

Virtus LifeSci Biotech Products ETF Stock Down 3.2%

Virtus LifeSci Biotech Products ETF stock traded down $3.36 during trading hours on Friday, hitting $100.26. The stock had a trading volume of 12,899 shares, compared to its average volume of 8,038. Virtus LifeSci Biotech Products ETF has a 12-month low of $60.80 and a 12-month high of $105.21. The stock’s 50-day moving average price is $89.98 and its 200-day moving average price is $85.28.

Virtus LifeSci Biotech Products ETF Company Profile

(Get Free Report)

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.